glp-1 agonist price "In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.", Jens Juul Holst, MD, PhD, GLP-1 Agonists Market Report 2025-2033,
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
![glp-1 agonist price "In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.", Jens Juul Holst, MD, PhD, GLP-1 Agonists Market Report 2025-2033,](https://mnmimg.marketsandmarkets.com/Images/glp-1-analogues-market-content.webp)
![glp-1 agonist price "In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.", Jens Juul Holst, MD, PhD, GLP-1 Agonists Market Report 2025-2033,](https://images.ctfassets.net/jj2wf7627pjc/2LLM8wFIVK8qp78OgXGV65/ae3ebcd72703e3f46c817a3cda4013c2/Ro_March_GLP-1_Agonists_Explained_Graphic_3.png)
![glp-1 agonist price "In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.", Jens Juul Holst, MD, PhD, GLP-1 Agonists Market Report 2025-2033,](https://www.usatoday.com/gcdn/authoring/authoring-images/2026/02/04/USAT/88514390007-getty-images-2246550735.jpg?crop=5327,2997,x0,y0)
![glp-1 agonist price "In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.", Jens Juul Holst, MD, PhD, GLP-1 Agonists Market Report 2025-2033,](https://www.bocamedicalcare.com/wp-content/uploads/2024/10/new-glp-mobile-376x1024.jpg)
![glp-1 agonist price "In India, [#GLP-1 receptor agonists] are now sold at as low as 14% of the list price. Slowly but surely, we will get there with sufficient amounts and much lower prices.", Jens Juul Holst, MD, PhD, GLP-1 Agonists Market Report 2025-2033,](https://www.kff.org/wp-content/uploads/sites/7/2025/11/OSnNk-span-class-cf0-one-in-eight-adults-report-currently-using-glp-1-drugs-including-much-larger-shares-span-span-class-cf1-span-span-class-cf0-of-those-with-conditions-these-drugs-are-prescribed-for-span-.png)























